Stock listing

NASDAQ:ICPT Intercept Pharmaceuticals Inc Stock

Follow Intercept Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ICPT

$19.00 USD

Close on Nov 14, 2023 · No longer trades

Oct 11, 2012 to last close -2.1% · monthly closes, Oct 11, 2012 – Nov 14, 2023
Lowest – highest close
$9.17 – $462.26 USDSince Oct 11, 2012 · lowest May 24, 2023 · highest Mar 14, 2014

Delisted NASDAQ:ICPT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ICPT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Intercept Pharmaceuticals Inc on 6ix

Calls
10 calls with a replay · 10 with a transcript · latest Aug 2, 2023
Decks
3 decks · latest Jan 11, 2023

Events

Open Events

Decks

DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2023Conference23 slidesJan 11, 2023
Technical Presentation (July 2022)Technical9 slidesJul 7, 2022
Investor Day (December 2015)Investor day92 slidesDec 1, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniel G. Welch
Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); AveXis Inc (Director · Feb 10, 2016 – May 15, 2018 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Hyperion Therapeutics Inc (Director · Aug 23, 2012 – May 7, 2015 · Past); Seagen Inc (Director · Jun 13, 2007 – Dec 14, 2023 · Past); InterMune Inc (Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past)
Director · Nov 24, 2015 – May 28, 2020 · Past
Srinivas Akkaraju
Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Mar 18, 2025); Alumis Inc. (Founder and Managing Member, Samsara BioCapital · Since at least Jun 27, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 23, 2024); Mineralys Therapeutics, Inc. (Board Member · Since at least Feb 9, 2023); Scholar Rock Holding Corporation (Director · Since at least Jul 26, 2022); Jiya Acquisition Corp (Director · Sep 23, 2022 – Sep 23, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 1, 2022 – Sep 16, 2024 · Past); Aduro Biotech Inc (Director · May 26, 2022 – Aug 11, 2023 · Past)
Director · May 25, 2022 – Nov 8, 2023 · Past
Gino Santini
Other companies: COMPASS Pathways Plc (CHAIRMAN OF THE BOARD · Since at least Sep 3, 2024); Collegium Pharmaceutical, Inc. (Chairman of the Board · Since at least Sep 10, 2015); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Jun 3, 2021 · Past); Vitae Pharmaceuticals Inc (Director · May 26, 2016 – Oct 25, 2016 · Past); AMAG Pharmaceuticals Inc (Director · May 19, 2016 – Nov 16, 2020 · Past); Horizon Pharma PLC (Director · May 3, 2016 – May 3, 2018 · Past)
Director · Nov 24, 2015 – Nov 8, 2023 · Past
Keith Gottesdiener
Other companies: Septerna, Inc. (Director · Since at least Sep 25, 2025); Prime Medicine, Inc. (See Remarks, Director · Oct 19, 2022 – May 8, 2025 · Past); Rhythm Pharmaceuticals, Inc. (CEO & President, Director · Oct 4, 2017 – Mar 9, 2020 · Past)
Director · Jul 19, 2016 – Nov 8, 2023 · Past
Nancy Miller-Rich
Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Aldeyra Therapeutics, Inc. (Director · Since at least Jan 13, 2020); Kadmon Holdings Inc (Director · Aug 13, 2020 – Nov 9, 2021 · Past)
Director · Apr 24, 2018 – Nov 8, 2023 · Past
Bryan Ball
Other companies: Whitehawk Therapeutics, Inc. (Chief Technical Operations Officer · Since at least Apr 23, 2024); Immunomedics Inc (Chief Quality Officer · Mar 5, 2019 – Oct 23, 2020 · Past)
Chief Qual. Officer & SVP Ops. · Jan 11, 2021 – Jul 11, 2022 · Past
Gail Cawkwell
Other companies: Aclaris Therapeutics, Inc. (Chief Medical Officer · Jun 27, 2022 – Jul 1, 2023 · Past)
SVP, Med Affairs, Safety & PV · Dec 4, 2018 – Feb 12, 2022 · Past
Jason Campagna
Other companies: Q32 Bio Inc. (Chief Medical Officer · Mar 25, 2024 – Feb 24, 2025 · Past)
Chief Medical Officer · Dec 1, 2019 – Jan 22, 2021 · Past
Lisa Bright
Other companies: Ascendis Pharma A/S (Board Member · Since at least Mar 18, 2026)
President, International · Apr 1, 2019 – Jul 1, 2020 · Past
Lisa DeFrancesco
Other companies: Lexicon Pharmaceuticals, Inc. (Senior Vice President, Investor Relations and Corporate Communications · Since at least Oct 2, 2024)
SVP, IR & Corp. Affairs · Feb 15, 2021 – Dec 31, 2021 · Past
All 17 people
PersonSeat
Lorenzo Tallarigo
Other companies: Eli Lilly and Company (President, Internat'l Opers. · Jan 20, 2006 – Mar 31, 2008 · Past)
Director · Jul 31, 2012 – Jul 7, 2014 · Past
Mark Pruzanski
Other companies: Equillium, Inc. (Director · Since at least Oct 11, 2018)
Director · Apr 9, 2013 – Nov 8, 2023 · Past
Nicole Williams
Other companies: Progenics Pharmaceuticals Inc (Director · Jun 8, 2016 – Jul 11, 2019 · Past)
Director · Jul 20, 2015 – Nov 20, 2015 · Past
Rachel McMinn
Other companies: Neurogene Inc. (Founder and Chief Executive Officer · Since at least Dec 18, 2023)
Chief Strategy Officer · Apr 30, 2014 – Oct 2, 2017 · Past
Richard J Kim
Other companies: Avadel Pharmaceuticals PLC (Chief Commercial Officer · Feb 15, 2021 – Feb 20, 2024 · Past)
President US Comm & Strat Mktg · May 1, 2017 – Dec 31, 2020 · Past
Luciano AdoriniSee Remarks · Apr 9, 2013 – Feb 1, 2016 · Past
M Michelle BerreyPresident, R&D and CMO · Nov 8, 2023 – Nov 8, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Intercept Pharmaceuticals Inc.